drugset / Trial / NCT00841321

Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis

NCT00841321

Phase 2 Completed 120 enrolled US Department of Veterans Affairs
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to see if treatment with Ginkgo improves cognitive function in people with multiple sclerosis who have cognitive problems.

Timeline

Start
2009-01
Primary completion
2010-11
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 120 mg Oral

Indications